Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RNA, U7 small nuclear 127 pseudogene (RNU7-127P) is a human **pseudogene** related to the U7 small nuclear RNA (snRNA) gene family, specifically named as the 127th annotated pseudogene in this family[1][5]. U7 small nuclear RNAs, when functional, are components of the U7 small nuclear ribonucleoprotein (snRNP) complex involved in the processing of histone pre-mRNAs, which is essential for cell cycle progression and histone biosynthesis[2][3]. However, as a pseudogene, RNU7-127P is **not believed to be transcribed into a functional RNA or protein** and does not have a known direct biological role or implication as a drug target[1][5]. Its presence may contribute to genomic architecture or function through regulatory RNAs, but there is no current evidence for direct involvement in disease, drug interactions, or utility as a biomarker[1][4][5].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA, U7 small nuclear 127 pseudogene (RNU7-127P).